Back to Journals » OncoTargets and Therapy » Volume 9

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Total article views   Abstract views HTML views PDF downloads Totals
8,887 Dovepress* 4,149 1,549+ 945 5,698
PubMed Central* 0 3,189 889 3,189
Totals 4,149 4,738 1,834 8,887
*Since 20 October 2016
+Since July 2016

View citations on PubMed Central and Google Scholar